Making a big difference for the smallest patient populations
Diagnosing a rare disease is difficult, but accessing appropriate therapies can be an even greater challenge. Patients with rare conditions face unique hurdles, such as the cost of lifelong treatment, difficulty managing modifications in therapy, or transitioning from hospital-based treatment to home care. Such challenges create opportunities for non-adherence. Choosing a knowledgeable commercialization partner will help you succeed where complexity exists.
Connecting those across the continuum of care
We connect patients and caregivers to education and advocacy resources within the rare disease community. Working to help patients realize the full benefit of customizable support, we streamline communications between patients, providers and advocacy groups, creating a consistent and holistic treatment experience.
Do’s and don'ts for orphan drug support programs
Launching a rare disease drug presents unique challenges and risks. Having helped steer over 85 products to commercial success, we’ve developed a few “do’s and don’ts” to help simplify the process.Read the article